Application Nr Approved Date Route Status External Links
ANDA209664 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pregabalin Capsules Are Indicated For: • Management Of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy • M Anagement Of Postherpetic Neuralgia •adjunctive Therapy For The Treatment Of Partial-Onset Seizures In Patients 17 Years Of Age And Older • M Anagement Of Fibromyalgia • M Anagement Of Neuropathic Pain Associated With Spinal Cord Injury Pediatric Use Information Is Approved For Pfizer’s Lyrica (Pregabalin) Capsules And Oral Solution Products. However, Due To Pfizer’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Pediatric Information. Pregabalin Capsules Are Indicated For: • Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (Dpn) (1) • Postherpetic Neuralgia (Phn) (1) • Adjunctive Therapy For For The Treatment Of Partial-Onset Seizures In Patients 17 Years Of Age And Older (1) • Fibromyalgia (1) • Neuropathic Pain Associated With Spinal Cord Injury (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pregabalin PREGABALIN ZINC5152

Comments